Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Orlistat Market Size Shifted, And What Is the Outlook Through 2034?
The market size for Orlistat has witnessed significant expansion in the past few years. This market is projected to rise from $3.03 billion in 2024 to $3.2 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. Factors contributing to the growth in the past years include increased understanding of obesity-related health dangers, recognition of orlistat as a prescription drug by regulatory authorities, availability of over-the-counter orlistat in smaller doses, recommendations by physicians, and the elevated costs associated with obesity-related healthcare.
The market size of orlistat is projected to witness significant expansion in the upcoming years, predicted to rise to $4.07 billion in 2029 with a CAGR of 6.1%. Factors contributing to this anticipated growth within the predicted period include increased expenditure on health care for obesity treatments, stagnant lifestyles complemented by poor dietary habits, government initiatives encouraging weight loss and healthy living, an aging population, and the transitioning of prescriptions to over-the-counter medications. Some of the major trends forecasted for this period consist of diet plans powered by artificial intelligence, telehealth facilities, devices with automation that remind patients about their medication and monitor compliance, workouts through virtual reality, and digital therapeutics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18422&type=smp
What are the Fundamental Drivers and Innovations Shaping the Orlistat Market?
The escalating rates of obesity are anticipated to fuel the expansion of the orlistat market. Obesity, a health condition marked by an overabundance of body fat, can have detrimental effects on one’s health. It’s typically determined by a body mass index (BMI) of 30 or more. This rise in obesity is attributed to factors such as inadequate diets, a lack of physical activity, and stationary lifestyles. Orlistat aids in the management of obesity by preventing the absorption of dietary fats, which assists in weight reduction and maintenance. It is commonly recommended in conjunction with a calorie-reduced diet and regular physical activity for more optimal outcomes. As an illustration, in March 2022, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, stated that over 1 billion people worldwide were affected by obesity, including 650 million adults, 340 million teenagers, and 39 million children. This number continues to surge; by 2025, it’s estimated that about 167 million people — both adults and children — will suffer from deteriorating health as a result of being overweight or obese. Consequently, the escalating obesity rates are propelling the growth of the orlistat market.
How Is the Orlistat Market Segmented?
The orlistatmarket covered in this report is segmented –
1) By Type: 120 Milligram (Mg); 60 Milligram(Mg)
2) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
3) By Application: Weight-Reducing Aid; Other Applications
Subsegments:
1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat; Over-The-Counter (OTC) 120 Mg Orlistat
2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat; Prescription-Based 60 Mg Orlistat
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18422&type=smp
Which Regions Are Driving the Next Phase of the Orlistat Market Growth?
North America was the largest region in the orlistat market in 2024. The regions covered in the orlistat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Orlistat Market?
Leading corporations in the orlistat market are introducing innovative products such as weight reduction medications, aiming to improve personal hygiene and convenience through cutting-edge technology and design. This type of drug is engineered to assist people in losing weight by suppressing hunger, accelerating metabolism, or preventing fat absorption. For example, in November 2023, Eli Lilly and Company, an American pharmaceutical firm, gained approval from the US Food and Drug Administration (FDA) for Zepbound (tirzepatide) injection, its latest weight loss medication. Zepbound stands as the only approved treatment that triggers two incretin hormone receptors, GIP and GLP-1, targeting a fundamental cause of excessive weight. The drug is recommended for use alongside a calorie-restricted diet and augmented physical activity for enduring weight management in adults suffering from obesity (BMI =30 kg/m²) or overweight (BMI =27 kg/m²) with at least one condition related to weight.
View the full report here:
https://www.thebusinessresearchcompany.com/report/orlistat-global-market-report
How Is the Orlistat Market Defined and What Are Its Core Parameters?
Orlistat is a medication used to aid weight loss by preventing the absorption of fats from the diet, thereby reducing calorie intake. It works by inhibiting the enzyme lipase, which is necessary for the breakdown of dietary fats in the intestine. It is typically prescribed for individuals who are obese or overweight and is most effective when combined with a low-fat diet and regular exercise.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18422
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model